The Department of Biotechnology (DBT) on Thursday announced the scientific completion of India’s first locally produced quadrivalent human papillomavirus (qHPV) vaccine against cervical cancer.
- Lack of standardized screening linked to an increased incidence of many HPV-related cancers
- The decline in HPV-associated cervical cancer informs about screening and vaccination efforts for other virus-caused diseases
- Why a woman transmitted a sexually transmitted infection for almost two years
- Global Women’s Health Therapeutics Market Business Strategy, News, Latest Trends, and Demand 2028 – The Courier